These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 19729359

  • 1. KIT(D816V+) systemic mastocytosis associated with KIT(D816V+) acute erythroid leukaemia: first case report with molecular evidence for same progenitor cell derivation.
    McClintock-Treep SA, Horny HP, Sotlar K, Foucar MK, Reichard KK.
    J Clin Pathol; 2009 Dec; 62(12):1147-9. PubMed ID: 19729359
    [Abstract] [Full Text] [Related]

  • 2. Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD).
    Sotlar K, Colak S, Bache A, Berezowska S, Krokowski M, Bültmann B, Valent P, Horny HP.
    J Pathol; 2010 Apr; 220(5):586-95. PubMed ID: 20112369
    [Abstract] [Full Text] [Related]

  • 3. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
    Pullarkat VA, Bueso-Ramos C, Lai R, Kroft S, Wilson CS, Pullarkat ST, Bu X, Thein M, Lee M, Brynes RK.
    Am J Hematol; 2003 May; 73(1):12-7. PubMed ID: 12701114
    [Abstract] [Full Text] [Related]

  • 4. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
    Sotlar K, Bache A, Stellmacher F, Bültmann B, Valent P, Horny HP.
    J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278
    [Abstract] [Full Text] [Related]

  • 5. Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V.
    Ustun C, Corless CL, Savage N, Fiskus W, Manaloor E, Heinrich MC, Lewis G, Ramalingam P, Kepten I, Jillella A, Bhalla K.
    Leuk Res; 2009 May; 33(5):735-41. PubMed ID: 18986703
    [Abstract] [Full Text] [Related]

  • 6. The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia.
    Nagai S, Ichikawa M, Takahashi T, Sato H, Yokota H, Oshima K, Izutsu K, Hangaishi A, Kanda Y, Motokura T, Chiba S, Yatomi Y, Kurokawa M.
    Exp Hematol; 2007 Nov; 35(11):1747-52. PubMed ID: 17976525
    [Abstract] [Full Text] [Related]

  • 7. Mastocytosis.
    Metcalfe DD.
    Novartis Found Symp; 2005 Nov; 271():232-42; discussion 242-9. PubMed ID: 16605139
    [Abstract] [Full Text] [Related]

  • 8. Distinct clonal origins of systemic mastocytosis and associated B-cell lymphoma.
    Kim Y, Weiss LM, Chen YY, Pullarkat V.
    Leuk Res; 2007 Dec; 31(12):1749-54. PubMed ID: 17544505
    [Abstract] [Full Text] [Related]

  • 9. Mastocytosis: state of the art.
    Horny HP, Sotlar K, Valent P.
    Pathobiology; 2007 Dec; 74(2):121-32. PubMed ID: 17587883
    [Abstract] [Full Text] [Related]

  • 10. The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis.
    Erben P, Schwaab J, Metzgeroth G, Horny HP, Jawhar M, Sotlar K, Fabarius A, Teichmann M, Schneider S, Ernst T, Müller MC, Giehl M, Marx A, Hartmann K, Hochhaus A, Hofmann WK, Cross NC, Reiter A.
    Ann Hematol; 2014 Jan; 93(1):81-8. PubMed ID: 24281161
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V.
    Böhm A, Sonneck K, Gleixner KV, Schuch K, Pickl WF, Blatt K, Peter B, Herrmann H, Schernthaner GH, Pehamberger H, Rabitsch W, Sperr WR, Valent P.
    Exp Hematol; 2010 Sep; 38(9):744-55. PubMed ID: 20553795
    [Abstract] [Full Text] [Related]

  • 12. Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3.
    Tzankov A, Sotlar K, Muhlematter D, Theocharides A, Went P, Jotterand M, Horny HP, Dirnhofer S.
    J Clin Pathol; 2008 Aug; 61(8):958-61. PubMed ID: 18663058
    [Abstract] [Full Text] [Related]

  • 13. Detection of the c-kit D816V mutation in systemic mastocytosis by allele-specific PCR.
    Schumacher JA, Elenitoba-Johnson KS, Lim MS.
    J Clin Pathol; 2008 Jan; 61(1):109-14. PubMed ID: 17526803
    [Abstract] [Full Text] [Related]

  • 14. Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis.
    Kristensen T, Broesby-Olsen S, Vestergaard H, Bindslev-Jensen C, Møller MB, Mastocytosis Centre Odense University Hospital (MastOUH).
    Eur J Haematol; 2012 Jul; 89(1):42-6. PubMed ID: 22469616
    [Abstract] [Full Text] [Related]

  • 15. The prognostic impact of c-KIT mutation in systemic mastocytosis associated with acute myeloid leukaemia patients.
    Won D, Chi HS, Shim H, Jang S, Park CJ, Lee JH.
    Leuk Res; 2013 Aug; 37(8):883-8. PubMed ID: 23683787
    [Abstract] [Full Text] [Related]

  • 16. Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone.
    Pullarkat V, Bedell V, Kim Y, Bhatia R, Nakamura R, Forman S, Sun J, Senitzer D, Slovak ML.
    Leuk Res; 2007 Feb; 31(2):261-5. PubMed ID: 16876862
    [Abstract] [Full Text] [Related]

  • 17. Systemic mastocytosis with associated clonal hematologic nonmast cell lineage disease: a clinicopathologic review.
    Stoecker MM, Wang E.
    Arch Pathol Lab Med; 2012 Jul; 136(7):832-8. PubMed ID: 22742558
    [Abstract] [Full Text] [Related]

  • 18. Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event.
    Jawhar M, Schwaab J, Schnittger S, Sotlar K, Horny HP, Metzgeroth G, Müller N, Schneider S, Naumann N, Walz C, Haferlach T, Valent P, Hofmann WK, Cross NC, Fabarius A, Reiter A.
    Leukemia; 2015 May; 29(5):1115-22. PubMed ID: 25567135
    [Abstract] [Full Text] [Related]

  • 19. "Occult" mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis.
    Sotlar K, Saeger W, Stellmacher F, Stahmer J, Jäckle S, Valent P, Horny HP.
    J Clin Pathol; 2006 Aug; 59(8):875-8. PubMed ID: 16873565
    [Abstract] [Full Text] [Related]

  • 20. Indolent systemic mastocytosis associated with atypical small lymphocytic lymphoma: a rare form of concomitant lymphoproliferative disease.
    Hauswirth AW, Födinger M, Fritz M, Müllauer L, Simonitsch-Klupp I, Streubel B, Chott A, Sperr WR, Jäger U, Valent P.
    Hum Pathol; 2008 Jun; 39(6):917-24. PubMed ID: 18448146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.